Acide fusarique, min 99 %, 250 mg, emballage en verre

(2E)-3-(4-bromophenyl)-1-(2,5-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

4-Methyl-2-({[3-trifluoromethyl)phenyl]sulfonyl}amino)pentanoic acid, 96.0%, 1g

3-(1,3-Dioxo-1,3-dihydroisoindol-2-yl)-propionaldehyde, 95.0%, 1g

5-(Hydroxymethyl)-1-methylpyrrolidin-2-one, 97%, 250mg

Methyl 3-Hydroxycyclohexanecarboxylate, 95.0%, 5g

ROTI®Cell DPBS, 500 ml

N,N-Dibutylacetamide, 95%, 250mg

N,N-méthylènebisacrylamide, 100 g

3,5-Difluorobenzaldehyde>98.0%(GC)25g

2-chloro-2-(4-chlorophenyl)acetic acid, 95.0%, 1g

Methyl 5-chloropentanoate, 95.0%, 1g

2-Phenyl-5-trifluoromethyl-2H-pyrazol-3-ol, 95.0%, 5g